entity

No

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about No: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

12Connections

30Hypotheses

20Analyses

7Outgoing

5Incoming

10Experiments

20Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

Outgoing (7)

Target	Relation	Type	Str
Learning And Memory	involved_in	process	0.90
Neuroprotection	mediates	process	0.90
NEURON	protects_against	cell_type	0.80
Neurons	modulates	cell_type	0.75
Astrocytes	modulates	cell_type	0.75
NEURONS	causes	cell_type	0.64
ASTROCYTES	causes	cell_type	0.64

Incoming (5)

Source	Relation	Type	Str
19371326	combines with	paper	0.90
MICROGLIAL CELL	produces	cell_type	0.80
DHT	inhibits	compound	0.80
MICROGLIA	activates	cell_type	0.64
PLGF	activates	protein	0.56

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
NLRP3 inflammasome amplification across AD and PD proteinopa	0.800	multi	Cross-disease neurodegeneration mechanis
Senescent Microglia Resolution via Maresins-Senolytics Combi	0.791	neurodegeneration	Neuroinflammation resolution mechanisms
Therapeutic Window Exists Because Amplified Signals (Not Bas	0.780	neurodegeneration	Do pathogenic LRRK2 mutations amplify vo

CX3CR1-TREM2 Integration for Synapse Pruning Normalization	0.776	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from E	0.770	neurodegeneration	Investigate mechanisms of epigenetic rep
Kinetic Modeling Predicts Threshold-Dependent Efficacy—Early	0.765	protein folding	Can chaperone enhancement approaches ove
TDP-43 Proteinopathy as a Cross-Disease Pathological Substra	0.760	neurodegeneration	Cross-disease neurodegeneration mechanis
p16^INK4a-CCF Axis as Senolytic Timing Biomarker	0.755	molecular biology	What is the optimal therapeutic window t
ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2	0.752	lipidomics	Lipid metabolism dysregulation in Alzhei
APOE4-Selective Lipid Nanoemulsion Therapy	0.742	neurodegeneration	Mechanistic role of APOE in neurodegener
Tau missorting transitions into an autonomous tau-seeding st	0.740	neurodegeneration	Does tau dendritic missorting persist in
SNCA Oligomer Binding to LAMP2A Cytosolic Tail Prevents Tors	0.733	neurodegeneration	-
Adenosine-Astrocyte Metabolic Reset	0.730	neurodegeneration	Sleep disruption as cause and consequenc
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A	0.728	neuroscience	APOE4-driven lipid metabolism dysregulat
TFAM overexpression creates mitochondrial donor-recipient gr	0.725	neurodegeneration	Mitochondrial transfer between astrocyte
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In	0.720	neurodegeneration	What molecular mechanisms drive microgli
Noradrenergic-Tau Propagation Blockade	0.711	neurodegeneration	Sleep disruption as cause and consequenc
H4: Senomorphic Compounds Preserve Astrocyte Function While	0.710	neurodegeneration	Do APOE4-driven senescent astrocytes cau
Peripheral Monocyte/Macrophage Infiltration Mimicking Microg	0.710	neuroinflammation	What causes IBA1 low/negative microglia
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In	0.709	neurodegeneration	Perivascular spaces and glymphatic clear
CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of A	0.705	-	What blood-brain barrier permeability ch
Spatiotemporal coupling between TRPML1-mediated lysosomal ca	0.705	neurodegeneration	What determines the specificity of calci
Targeted Butyrate Supplementation for Microglial Phenotype M	0.700	neurodegeneration	What are the mechanisms by which gut mic
AAV-Mediated APOE2/APOE3 Gene Delivery to Convert APOE Genot	0.700	neurodegeneration	APOE4 targeting in neurodegeneration
Pericyte-targeted senolysis or senomorphic therapy will bene	0.700	neurodegeneration	Does pericyte senescence drive BBB break
Mechanosensitive Ion Channel Reprogramming	0.700	neurodegeneration	Astrocyte reactivity subtypes in neurode
Plasma D-Dimer Elevation Reflects Fibrinogen Leakage and Sec	0.685	-	What blood-brain barrier permeability ch
Closed-loop transcranial focused ultrasound with gamma entra	0.000	Alzheimer's disease	Circuit-level neural dynamics in neurode

Mentioning Analyses (20)

Scientific analyses that reference this entity

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-28 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.640

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.780

Experiments (10)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Mobile App-Based Intervention for BPSD in Community-Dwelling Dementia	clinical	dementia with behavioral and p	0.950	0.00	human patients	proposed	N/A
Proposed experiment from debate on Senolytics targeting p16/p21+ senes	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis	validation	Neuroinflammation	0.400	0.50	human	proposed	$2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560]	Justice JN, Leng XI, LeBrasseur NK, Tchk	J Gerontol A Biol Sci Med Sci	2024	1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724]	Shang D, Wang L, Klionsky DJ, Cheng H, Z	Autophagy	2021	1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684]	He D, Wang D, Lu P, Yang N, Xue Z, Zhu X	Oncogene	2021	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143]	Chang J, Wang Y, Shao L, Laberge RM, Dem	Nat Med	2016	1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370]	Zhu Y, Tchkonia T, Pirtskhalava T, Gower	Aging Cell	2015	1
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036]	Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L	Biochemical pharmacology	2026	0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952]	Li X, Tang X, Zeng J, Duan L, Hou Z et a	Cell	2026	0
UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413]	Yang H, Li Y, Su J, Zhang H, Zhu W et al	Front Immunol	2026	0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289]	Zhang K, Na T, Jia C, Yuan X, Guo M, Yan	Stem cell research & therapy	2026	0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352]	Elsner C, Epasto LM, Cieren A, Gendreizi	Chembiochem : a European journ	2026	0
Exploring the key molecular mechanisms and immune microenvironment of oxidative [PMID:41591671]	Cai Z, Li J, Li T, Peng Q	Discover oncology	2026	0
Navitoclax acts synergistically with irradiation to induce apoptosis in preclini [PMID:41430412]	Vardon A, Haston S, Hamdi H, Cooksley G,	Scientific reports	2025	0
Combination of senolytic and pro-resolving mediator shows synergistic benefit in [PMID:synthetic_19]	Unknown	Nat Aging	2024	0
Senolytic treatment diminishes microglia and decreases severity of experimental [PMID:39487537]	Drake SS, Zaman A, Gianfelice C, Hua EM,	Journal of neuroinflammation	2024	0
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Park [PMID:36262883]	Unknown	Frontiers in aging neuroscienc	2023	0
SIRT1 and SIRT6: The role in aging-related diseases. [PMID:37499928]	You Y, Liang W	Biochim Biophys Acta Mol Basis	2023	0
CSF markers of microglial senescence predict cognitive decline in Alzheimer's di [PMID:synthetic_20]	Unknown	Ann Neurol	2023	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500]	Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH,	Aging cell	2023	0

Debates (20)

Multi-agent debates referencing this entity

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

closed · Rounds: 4 · Score: 0.68 · 2026-04-25

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

closed · Rounds: 4 · Score: 0.77 · 2026-04-25

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

The debate highlighted that long-term CRISPR expression triggers immune response

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The study demonstrates that high-neural glioblastoma cells form synapses with ne

closed · Rounds: 4 · Score: 0.62 · 2026-04-16

The abstract reveals FUS has a chaperone-like function regulating TAZ condensate

closed · Rounds: 4 · Score: 0.81 · 2026-04-16

Related Research

Hypotheses and analyses mentioning No in their description or question text

CX3CR1-TREM2 Integration for Synapse Pruning Normalization

Score: 0.776 · neurodegeneration · 2026-04-16

## Mechanistic Overview CX3CR1-TREM2 Integration for Synapse Pruning Normalization starts from the claim that modulating

H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasi

Score: 0.770 · neurodegeneration · 2026-04-22

## Mechanistic Overview H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasis starts from th

Kinetic Modeling Predicts Threshold-Dependent Efficacy—Early Intervention Requir

Score: 0.765 · protein folding · 2026-04-22

**Molecular Mechanism and Rationale** The therapeutic hypothesis centers on the kinetic constraints governing chaperone

TDP-43 Proteinopathy as a Cross-Disease Pathological Substrate

Score: 0.760 · neurodegeneration · 2026-04-28

TDP-43 misfolding and aggregation occurs as primary pathology in ALS/FTD (~95% and ~50% respectively) and as secondary p

p16^INK4a-CCF Axis as Senolytic Timing Biomarker

Score: 0.755 · molecular biology · 2026-04-21

**Molecular Mechanism and Rationale** The p16^INK4a-CCF axis represents a sophisticated temporal biomarker system that

ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synaptic

Score: 0.752 · lipidomics · 2026-04-25

The hypothesis proposes that ω-3 docosahexaenoic acid (DHA) is metabolized by CYP2J2 to generate protective epoxides tha

APOE4-Selective Lipid Nanoemulsion Therapy

Score: 0.742 · neurodegeneration · 2026-04-02

## Mechanistic Overview APOE4-Selective Lipid Nanoemulsion Therapy starts from the claim that modulating APOE within the

Tau missorting transitions into an autonomous tau-seeding state after transient

Score: 0.740 · neurodegeneration · 2026-04-25

Transient Aβ exposure induces dendritic tau missorting that then converts into a locally self-propagating tau oligomer/s

Adenosine-Astrocyte Metabolic Reset

Score: 0.730 · neurodegeneration · 2026-04-02

## Mechanistic Overview Adenosine-Astrocyte Metabolic Reset starts from the claim that modulating ADORA2A within the dis

Selective LXRβ agonists restore ABCA1/ABCG1 expression and APOE lipidation in AP

Score: 0.728 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The molecular basis for selective liver X receptor beta (LXRβ/NR1H2) agonism in A

TFAM overexpression creates mitochondrial donor-recipient gradients for directed

Score: 0.725 · neurodegeneration · 2026-04-02

## Mechanistic Overview TFAM overexpression creates mitochondrial donor-recipient gradients for directed organelle traff

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen

Noradrenergic-Tau Propagation Blockade

Score: 0.711 · neurodegeneration · 2026-04-02

## Mechanistic Overview Noradrenergic-Tau Propagation Blockade starts from the claim that modulating ADRA2A within the d

H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence

Score: 0.710 · neurodegeneration · 2026-04-22

## Mechanistic Overview H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence starts from the

No

Understanding Entity Pages

Wiki Pages (20)

Novel Therapy Index

Wnt Non-Canonical Signaling Pathways in Neurodegeneration

Novartis Alzheimer's Disease Phase 2 Trial (NCT07094516)

Non-Homologous End Joining in Neurodegeneration

University of North Carolina at Chapel Hill

Notch Signaling Pathway in Neurodegeneration

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Non-Dopaminergic Neurotransmitter Degeneration as Upstream Driver in Parkinson's Disease

Tanycytes: A Novel Tau Clearance Pathway from Brain to Blood

Non-coding RNAs in Neurodegeneration

Locus Coeruleus Noradrenergic Neurons

University of North Carolina (UNC)

Non-Motor Symptoms Treatment in Parkinson's Disease

Noradrenergic System in Neurodegeneration

Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)

Notch2 Protein

Locus Coeruleus Noradrenergic Projection Neurons

Novel Therapeutic Modalities Synthesis

Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and Biomarkers

Nogo Protein

Outgoing (7)

Incoming (5)

Targeting Hypotheses (30)

Mentioning Analyses (20)

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

What upstream mechanisms trigger p53 activation specifically in response to poly

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

What molecular mechanisms drive neuron-to-glioma synapse formation in high-neura

How do the seven novel ALS genes function in animal models to cause neurodegener

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodege

How can CRISPR systems achieve persistent therapeutic effects while avoiding chr

How can ESCRT or SNARE targeting achieve tau-specific effects without disrupting

Experiments (10)

Related Papers (20)

Debates (20)

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?

What is the molecular mechanism by which rutin inhibits tau aggregation and olig

The debate highlighted that long-term CRISPR expression triggers immune response

The study demonstrates that high-neural glioblastoma cells form synapses with ne

The abstract reveals FUS has a chaperone-like function regulating TAZ condensate

Related Research

CX3CR1-TREM2 Integration for Synapse Pruning Normalization

H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasi

Kinetic Modeling Predicts Threshold-Dependent Efficacy—Early Intervention Requir

TDP-43 Proteinopathy as a Cross-Disease Pathological Substrate

p16^INK4a-CCF Axis as Senolytic Timing Biomarker

ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synaptic

APOE4-Selective Lipid Nanoemulsion Therapy

Tau missorting transitions into an autonomous tau-seeding state after transient

Adenosine-Astrocyte Metabolic Reset

Selective LXRβ agonists restore ABCA1/ABCG1 expression and APOE lipidation in AP

TFAM overexpression creates mitochondrial donor-recipient gradients for directed

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Noradrenergic-Tau Propagation Blockade

H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence